✦ LIBER ✦

PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 together distinguish Alzheimer's disease from DLB patients

✍ Scribed by Marwan Sabbagh; Holly Shill; Andrew Siderowf; Michael J. Pontecorvo; Mark Mintun; Abhinay Joshi; Christopher Clark; Daniel Skrovonsky

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Amyloid Imaging with Florbetapir F 18 (1

✍ Marwan N. Sabbagh; Sandra A. Jacobson; Lucia I. Sue; Carolyn Liebsack; Albert S. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 122 KB

P2-005: PET imaging of amyloid-beta in A

✍ Doraiswamy, P. Murali; Edmunds, Stewart J.; Petrella, Jeffrey; Hawk, Thomas; Tur 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 54 KB

[18F]Flutemetamol amyloid-beta PET imagi

✍ Hatashita, Shizuo; Yamasaki, Hidetomo; Suzuki, Yutaka; Tanaka, Kumiko; Wakebe, D 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 613 KB

18F-AV-133 VMAT2 imaging in the differen

✍ Svetlana Pejoska; Christopher C. Rowe; John Drago; Nobuyuki Okamura; Rachel Mull 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 50 KB

18F-AV-133 VMAT2 Imaging in the Differen

✍ Pejoska, Svetlana; Rowe, Christopher C.; Drago, John; Okamura, Nobuyuki; Mulliga 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Imaging of amyloid β in Alzheimer's dise

✍ Christopher C Rowe; Uwe Ackerman; William Browne; Rachel Mulligan; Kerryn L Pike 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 289 KB